In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kipchu Tshering, Mir Misbahuddin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Sarja:Bangabandhu Sheikh Mujib Medical University Journal
Aiheet:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Linkit:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia